49 results on '"Sasaki, Hikaru"'
Search Results
2. Response to correspondence on an exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma
3. Disturbance Injection under Partial Automation: Robust Imitation Learning for Long-horizon Tasks
4. Bayesian Disturbance Injection: Robust Imitation Learning of Flexible Policies for Robot Manipulation
5. Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment
6. Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy
7. An exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma
8. Duality Cascades and Parallelotopes
9. Disturbance-Injected Robust Imitation Learning with Task Achievement
10. Gaussian Process Self-triggered Policy Search in Weakly Observable Environments
11. Correction: Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment
12. Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recurrence
13. Learning Re-grabbing Policies based on Grabbed Garbage Weight Estimation using In-bucket Images for Waste Cranes
14. Bayesian Disturbance Injection: Robust imitation learning of flexible policies for robot manipulation
15. The role of optimal cut-off diagnosis in 11C-methionine PET for differentiation of intracranial brain tumor from non-neoplastic lesions before treatment
16. Factors involved in maintaining Karnofsky Performance Status (≥ 50%) in glioblastoma, IDH-wildtype patients treated with temozolomide and radiotherapy.
17. The oligodendroglial histological features are not independently predictive of patient prognosis in lower-grade gliomas
18. A common deletion at BAK1 reduces enhancer activity and confers risk of intracranial germ cell tumors
19. 10005-ANGI-1 REGULATION OF ALTERNATIVE ANGIOGENIC FACTORS IN BEVACIZUMAB THERAPY FOR GLIOBLASTOMA
20. 10001-ACT-1 A MULTICENTER EXPLORATORY PHASE II STUDY OF NEOADJUVANT BEVACIZUMAB FOR NEWLY DIAGNOSED MALIGNANT GLIOMA - THE SECOND REPORT
21. SURG-01. DIFFERENTIATION OF GLIOBLASTOMA AND MALIGNANT MENINGIOMA FROM NORMAL BRAIN BY TISSUE STIFFNESS UTILIZING MICROSURGICAL FORCEPS EQUIPPED WITH HAPTICS TECHNOLOGY
22. EXTH-01. STEM CELL THERAPY FOR LEPTOMENINGEAL DISEASE
23. CTNI-45. UPFRONT CHEMOTHERAPY AND SUBSEQUENT RESECTION UTILIZING NEOADJUVANT STRATEGY FOR OLIGODENDROGLIOMAS
24. コウカケイ ダイガクセイ ノ コミュニケーション ノ ケイジテキ ヘンカ ト メンタルヘルス ノ カンケイ
25. ニュウガク ショキ ノ ガクギョウ ヘノ ツマズキ カン オヨビ シンリテキ リスク ト セイシンテキ フケンコウ オヨビ ダイガクセイカツ ノ ジュウジツカン テイカ ノ ハッセイ リスク
26. An exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma
27. 原発性悪性脳腫瘍に対する光線力学的療法:慶應義塾大学病院における初期治療経験
28. Duality cascades and parallelotopes
29. 初年次学生の修学に関するリスク特性と精神的不健康、大学不適応症状、不登校症状の発生リスクの関係;Relationships between risk characteristics related to study of university freshmen and the relative risk of mental illness, university maladaptation, and school refusal behavior
30. Multi-step motion learning by combining learning-from-demonstration and policy-search
31. Policy Optimization for Waste Crane Automation from Human Preferences
32. Disturbance Injection under Partial Automation: Robust Imitation Learning for Long-horizon Tasks
33. BOT-3 GENOME-WIDE ASSOCIATION STUDY OF INTRACRANIAL GERM CELL TUMORS: A COMMON DELETION ATBAK1 ATTENUATES THE ENHANCER ACTIVITY AND CONFERS RISK FOR THE BRAIN TUMORS IN CHILDREN ADOLESCENTS AND YOUNG ADULTS
34. LW-8 TREATMENT STRATEGY FOR OLIGODENDROGLIOMAS WITH NEOADJUVANT STRATEGY AND STAGED RESECTION UTILIZING THEIR CHEMOTHERAPEUTIC RESPONSIVENESS
35. MPC-1 IMMUNOHISTOLOGICAL COMPREHENSIVE ANALYSIS OF ANGIOGENIC FACTORS OTHER THAN VEGF IN GLIOBLASTOMAS IN RELATION TO THE USE OF BEVACIZUMAB
36. ACT-1 A PROSPECTIVE MULTICENTER PHASE I/IIA STUDY OF PREOPERATIVE NEOADJUVANT BEVACIZUMAB FOR NEWLY DIAGNOSED GLIOBLASTOMA
37. Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114C
38. SURG-21. DEVELOPMENT OF MICROSURGICAL FORCEPS EQUIPPED WITH HAPTICS TECHNOLOGY FOR IN SITU DIFFERENTIATION OF TUMOR TISSUE FROM NORMAL BRAIN DURING MICROSURGERY BY TISSUE STIFFNESS
39. Impact of Neoadjuvant Bevacizumab on Neuroradiographic Response and Histological Findings Related to Tumor Stemness and the Hypoxic Tumor Microenvironment in Glioblastoma: Paired Comparison Between Newly Diagnosed and Recurrent Glioblastomas
40. Gaussian Process Self-triggered Policy Search in Weakly Observable Environments
41. Disturbance-injected Robust Imitation Learning with Task Achievement
42. Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114C.
43. In-bucket Garbage Shape Estimation based on Time-varying Gaussian Process Implicit Surface using Proximity Sensor
44. Coarse2Fine Robust Imitation Learning
45. Anti-EGFR VHH-armed death receptor ligand-engineered stem cells have therapeutic efficacy in basal-like breast cancer brain metastasis
46. Bayesian Optimization for Waste Crane Automation with Garbage Inhomogeneity
47. Subtemporal Epidural and Interdural Approach for Greater Superficial Petrosal Nerve Schwannomas
48. [Meningioma].
49. [Glioblastoma That Does Not Improve with Standard Treatment: Standard and Personalized Treatment Making The Most of Limited Modalities].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.